Skip to content

Company
PIpeline
For Investors
Contact

Investors

Press Releases

Choose Year
Search Press Releases

Found 265 Results

June 2, 2022

Relmada Therapeutics to Participate in the 2022 Jefferies Global Healthcare Conference

May 25, 2022

Relmada Therapeutics to Present Data at the American Society of Clinical Psychopharmacology 2022 Annual Meeting

May 5, 2022

Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results

April 29, 2022

Relmada Therapeutics Announces Publication of REL-1017 Preclinical Data in Frontiers in Pharmacology

April 28, 2022

Relmada Therapeutics to Report First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 5, 2022

April 4, 2022

Relmada Therapeutics to Present Data at the Ketamine & Related Compounds International Hybrid Conference 2022

March 23, 2022

Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results

March 16, 2022

Relmada Therapeutics to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call and Webcast on March 23, 2022

March 10, 2022

Relmada Therapeutics to Participate in Fireside Chats at Two Upcoming Healthcare Events

February 23, 2022

Relmada Therapeutics Announces Top-Line Results of Study Evaluating REL-1017 vs Ketamine for Abuse Potential

«...7 8910 11 12...»

IR Contact

FIRST NAME LAST NAME
COMPANY NAME
EMAIL@COMPANY.COM

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Unsubscribe

Loading...

Copyright © 2026 Relmada Therapeutics | Powered by Astra WordPress Theme

Scroll to Top